Table 1:
Number of Patients | 48,274 |
Patients with medication treatment episodes only | 23,992 (49.70%) |
Patients with non-medication treatment episodes only | 13,497 (27.96%) |
Patients with both medication and non-medication treatment episodes | 10,785 (22.34%) |
Number of Follow-Up Episodes | 185,568 |
During non-medication treatment | 44,176 (23.81%) |
During medication treatment* | 55,016 (29.65%) |
After non-medication treatment | 37,863 (20.40%) |
After medication treatment | 48,513 (26.14%) |
Average Length of Follow up Episodes | 123 days |
During non-medication treatment | 22 days |
During medication treatment | 248 days |
After non-medication treatment | 118 days |
After medication treatment | 79 days |
Average In-Treatment Episodes per Patient | 2 |
Substances Involved in Opioid Overdose Deaths During Follow Up | 371 |
Prescription opioids | 130 (35.04%) |
Methadone | 114 (30.73%) |
Heroin | 241 (64.96%) |
Fentanyl | 213 (57.41%) |
Of the 55,016 medication treatment episodes, 93.31% involved methadone, and 6.69% involved buprenorphine